A detailed history of Hrt Financial LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 54,066 shares of HRMY stock, worth $1.84 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
54,066
Previous 31,780 70.13%
Holding current value
$1.84 Million
Previous $958,000 125.37%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$30.0 - $39.95 $668,580 - $890,325
22,286 Added 70.13%
54,066 $2.16 Million
Q2 2024

Aug 12, 2024

BUY
$28.81 - $33.01 $915,581 - $1.05 Million
31,780 New
31,780 $958,000
Q1 2023

May 12, 2023

BUY
$30.8 - $53.92 $255,917 - $448,021
8,309 New
8,309 $271,000
Q1 2021

May 17, 2021

SELL
$27.56 - $40.37 $931,858 - $1.36 Million
-33,812 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$31.74 - $51.34 $1.07 Million - $1.74 Million
33,812 New
33,812 $1.22 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.